Anti‐myelin antibodies in multiple sclerosis: clinically useful?

Por Polman, C H, Killestein, J
Publicado em 2006

Drug treatment of multiple sclerosis

Por Polman, C H, Uitdehaag, B M J
Publicado em 2000

Magnetic resonance imaging studies in multiple sclerosis twins.

Por Uitdehaag, B M, Polman, C H, Valk, J, Koetsier, J C, Lucas, C J
Publicado em 1989

Diffusely Abnormal White Matter in Progressive Multiple Sclerosis: In Vivo Quantitative MR Imaging Characterization and Comparison between Disease Types

Por Vrenken, H., Seewann, A., Knol, D.L., Polman, C.H., Barkhof, F., Geurts, J.J.G.
Publicado no AJNR Am J Neuroradiol (2010)

Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humans.

Por Rep, M. H., van Oosten, B. W., Roos, M. T., Adèr, H. J., Polman, C. H., van Lier, R. A.
Publicado em 1997

No evidence of misdiagnosis in patients with multiple sclerosis and repeated positive anticardiolipin antibody testing based on magnetic resonance imaging and long term follow‐up

Por Liedorp, M, Sanchez, E, van Hoogstraten, I M W, von Blomberg, B M E, Barkhof, F, Polman, C H
Publicado em 2007

Normal-Appearing White Matter Changes Vary with Distance to Lesions in Multiple Sclerosis

Por Vrenken, H., Geurts, J.J.G., Knol, D.L., Polman, C.H., Castelijns, J.A., Pouwels, P.J.W., Barkhof, F.
Publicado no AJNR Am J Neuroradiol (2006)

Cognition in MS correlates with resting-state oscillatory brain activity: An explorative MEG source-space study()

Por Van der Meer, M.L., Tewarie, P., Schoonheim, M.M., Douw, L., Barkhof, F., Polman, C.H., Stam, C.J., Hillebrand, A.
Publicado em 2013

Axon loss is an important determinant of weakness in multifocal motor neuropathy

Por Van Asseldonk, J T H, Van den Berg, L H, Kalmijn, S, Van den Berg‐Vos, R M, Polman, C H, Wokke, J H J, Franssen, H
Publicado em 2006

Proxy measurements in multiple sclerosis: agreement between patients and their partners on the impact of multiple sclerosis in daily life

Por van der Linden, F A H, Kragt, J J, Hobart, J C, Klein, M, Thompson, A J, van der Ploeg, H M, Polman, C H, Uitdehaag, B M J
Publicado em 2006

Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT

Por Edan, G, Kappos, L, Montalbán, X, Polman, C H, Freedman, M S, Hartung, H-P, Miller, D, Barkhof, F, Herrmann, J, Lanius, V, Stemper, B, Pohl, C, Sandbrink, R, Pleimes, D
Publicado em 2014

Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis

Por Altmann, D R., Jasperse, B, Barkhof, F, Beckmann, K, Filippi, M, Kappos, L D., Molyneux, P, Polman, C H., Pozzilli, C, Thompson, A J., Wagner, K, Yousry, T A., Miller, D H.
Publicado em 2009

White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis

Por Wiebenga, O.T., Schoonheim, M.M., Hulst, H.E., Nagtegaal, G.J.A., Strijbis, E.M.M., Steenwijk, M.D., Polman, C.H., Pouwels, P.J.W., Barkhof, F., Geurts, J.J.G.
Publicado no AJNR Am J Neuroradiol (2016)

Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis

Por van den Elskamp, I. J., Boden, B., Dattola, V., Knol, D. L., Filippi, M., Kappos, L., Fazekas, F., Wagner, K., Pohl, C., Sandbrink, R., Polman, C. H., Uitdehaag, B. M. J., Barkhof, F.
Publicado em 2010

Genetic Correlations of Brain Lesion Distribution in Multiple Sclerosis: An Exploratory Study

Por Sombekke, M.H., Vellinga, M.M., Uitdehaag, B.M.J., Barkhof, F., Polman, C.H., Arteta, D., Tejedor, D., Martinez, A., Crusius, J.B.A., Peña, A.S., Geurts, J.J.G., Vrenken, H.
Publicado no AJNR Am J Neuroradiol (2011)

A search for new MRI criteria for dissemination in space in subjects with a clinically isolated syndrome

Por Korteweg, T., Tintore, M., Uitdehaag, B. M. J., Knol, D. L., Vrenken, H., Rovira, A., Frederiksen, J., Miller, D. H., Fernando, K., Filippi, M., Agosta, F., Rocca, M. A., Fazekas, F., Enzinger, C., Parry, A., Polman, C. H., Montalban, X., Barkhof, F.
Publicado em 2009

Multicontrast MR Imaging at 7T in Multiple Sclerosis: Highest Lesion Detection in Cortical Gray Matter with 3D-FLAIR

Por Kilsdonk, I.D., de Graaf, W.L., Soriano, A. Lopez, Zwanenburg, J.J., Visser, F., Kuijer, J.P.A., Geurts, J.J.G., Pouwels, P.J.W., Polman, C.H., Castelijns, J.A., Luijten, P.R., Barkhof, F., Wattjes, M.P.
Publicado no AJNR Am J Neuroradiol (2013)